IRIS
MAZZOCCA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.965
AS - Asia 2.059
EU - Europa 1.687
SA - Sud America 440
AF - Africa 72
OC - Oceania 12
AN - Antartide 1
Totale 9.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.889
SG - Singapore 807
IT - Italia 579
CN - Cina 514
BR - Brasile 342
HK - Hong Kong 242
SE - Svezia 234
RU - Federazione Russa 199
VN - Vietnam 179
DE - Germania 177
FR - Francia 128
FI - Finlandia 96
GB - Regno Unito 83
IN - India 62
UA - Ucraina 59
BD - Bangladesh 43
CA - Canada 37
IQ - Iraq 33
NL - Olanda 30
AR - Argentina 27
ID - Indonesia 26
MX - Messico 24
SA - Arabia Saudita 22
ZA - Sudafrica 21
EC - Ecuador 20
BE - Belgio 19
ES - Italia 19
PK - Pakistan 17
PL - Polonia 16
VE - Venezuela 15
TR - Turchia 14
CI - Costa d'Avorio 13
JP - Giappone 13
CO - Colombia 12
AU - Australia 11
PH - Filippine 11
LB - Libano 9
LT - Lituania 9
AT - Austria 8
EG - Egitto 8
IE - Irlanda 8
UZ - Uzbekistan 8
IR - Iran 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
NP - Nepal 6
PE - Perù 6
CL - Cile 5
KE - Kenya 5
MA - Marocco 5
PA - Panama 5
UY - Uruguay 5
BH - Bahrain 4
BO - Bolivia 4
JO - Giordania 4
OM - Oman 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
PS - Palestinian Territory 3
PY - Paraguay 3
RO - Romania 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
KR - Corea 2
LK - Sri Lanka 2
NO - Norvegia 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MU - Mauritius 1
MV - Maldive 1
MW - Malawi 1
MZ - Mozambico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.231
Salva come PNG Salva come JPEG
Città #
Ashburn 565
Fairfield 529
Woodbridge 443
Singapore 426
Houston 341
Chandler 329
Seattle 241
Hong Kong 238
San Jose 203
Nyköping 192
Cambridge 190
Wilmington 182
Milan 167
Jacksonville 158
Ann Arbor 150
Beijing 140
Bari 98
Dallas 88
Los Angeles 79
Lauterbourg 71
New York 66
Lawrence 63
Roxbury 62
Ho Chi Minh City 58
Nanjing 56
Rome 54
Des Moines 44
Santa Clara 44
Boardman 41
Helsinki 40
Hanoi 36
Brooklyn 35
Columbus 33
Inglewood 31
North Bergen 31
Princeton 29
Buffalo 26
Munich 26
Dearborn 22
Shenyang 21
São Paulo 21
Council Bluffs 20
Brussels 17
San Diego 17
Dong Ket 16
Falkenstein 16
Figino 16
London 16
Chicago 15
Frankfurt am Main 15
Guangzhou 15
Jakarta 15
Jiaxing 15
Nanchang 15
Nuremberg 15
Rio de Janeiro 15
Abidjan 13
Hebei 13
Paris 13
Baghdad 12
Mumbai 12
Riyadh 12
Tokyo 12
Zhengzhou 12
Moscow 11
Orem 11
San Francisco 11
Toronto 11
Eindhoven 10
Haiphong 10
Hangzhou 10
Jinan 10
Mexico City 10
Montreal 10
Boston 9
Changsha 9
Ningbo 9
Ostuni 9
San Mateo 9
The Dalles 9
Tianjin 9
Turin 9
Warsaw 9
Belo Horizonte 8
Da Nang 8
Dublin 8
Johannesburg 8
Norwalk 8
Redwood City 8
Atlanta 7
Chennai 7
Dhaka 7
Leawood 7
Porto Alegre 7
Stockholm 7
Taizhou 7
Tashkent 7
Turku 7
Ardabil 6
Bellwood 6
Totale 6.314
Salva come PNG Salva come JPEG
Nome #
Autotaxin is a novel molecular identifier of type I endometrial cancer 215
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 200
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D 181
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells 179
Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE 176
T(14;18) translocation in chronic hepatitis C virus infection 173
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology 172
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 170
Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells 169
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment 168
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 160
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. 155
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer 155
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer 154
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm 152
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 151
Clinical Usefulness of Cancer Antigen 15-3 in Breast Cancer Patients Before and After Surgery 141
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease 140
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications 139
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 138
cAMP-dependent protein kinase of mitochondria. Structure and possible role of the substrates 138
null 131
Sorafenib: 10 years after the first pivotal trial 130
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration 127
Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma 127
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions 127
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 125
Frictional purpuric eruption associated with angiotensin II receptor blockers 123
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L 123
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 121
Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond 121
The integrin, α6β1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells 121
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth 121
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 120
Pathobiology of Hepatocellular Carcinoma and Clinical Impact 120
Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance 119
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro 119
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells 118
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer 117
The metastatic process: methodological advances and pharmacological challenges 113
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 111
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 108
Tetraspanin-enriched microdomains and hepatocellular carcinoma progression. 107
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 107
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 106
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 104
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 104
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 104
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function 101
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 98
Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer 98
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 97
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth 96
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. 95
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines 95
The TGF-β signaling pathway as a pharmacological target in hepatocellular carcinoma 95
Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated mets predict colorectal liver metastases outgrowth 95
Effect of change of interleukin-6 over time on gait speed response: Results from the lifestyle interventions and independence for elders study 94
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection 94
Tetraspanins CD9 and CD81 are molecular partners of trimeric FcεRI on human antigen-presenting cells 92
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer 91
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice 90
Inhibiting TGF-β signaling in hepatocellular carcinoma 90
Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 87
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 83
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation 79
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma 78
Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin 78
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 78
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy 75
Targeting TGF-βRI inhibits activation of β1 integrin and blocks vascular invasion in Hepatocellular Carcinoma (HCC) 75
Implications of the lysophosphatidic acid signaling axis in liver cancer 75
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma 74
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 72
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy 72
Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis 70
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer 62
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells 59
The perplexity of targeting genetic alterations in hepatocellular carcinoma 58
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 56
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 54
Chronic Inflammation in Obesity and Cancer Cachexia 46
The systemic evolutionary theory of the origin of cancer (SETOC): an update 39
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells 36
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance 31
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer 31
The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System 27
New hypotheses for cancer generation and progression 17
Totale 9.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.734
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022485 17 61 5 15 34 30 28 26 34 24 93 118
2022/2023814 122 107 68 66 94 95 10 99 109 4 30 10
2023/2024240 23 51 14 28 18 55 8 8 1 7 11 16
2024/20251.441 21 14 97 50 47 108 183 109 117 63 189 443
2025/20263.293 465 123 244 387 367 151 349 114 336 313 99 345
2026/2027119 119 0 0 0 0 0 0 0 0 0 0 0
Totale 9.533